Literature DB >> 15755985

Targeted therapy: wave of the future.

Mark D Pegram1, Richard Pietras, Alex Bajamonde, Pamela Klein, Gwen Fyfe.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15755985     DOI: 10.1200/JCO.2005.11.029

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  Novel beta-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy.

Authors:  Girja S Shukla; David N Krag
Journal:  J Drug Target       Date:  2010-02       Impact factor: 5.121

Review 2.  Rethinking the metastatic cascade as a therapeutic target.

Authors:  Lida A Mina; George W Sledge
Journal:  Nat Rev Clin Oncol       Date:  2011-04-19       Impact factor: 66.675

3.  Cancer cell-specific internalizing ligands from phage displayed beta-lactamase-peptide fusion libraries.

Authors:  Girja S Shukla; David N Krag
Journal:  Protein Eng Des Sel       Date:  2010-03-10       Impact factor: 1.650

4.  Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor.

Authors:  Xianke Zeng; Hua Zhang; Annabell Oh; Yan Zhang; Douglas Yee
Journal:  Breast Cancer Res Treat       Date:  2011-08-18       Impact factor: 4.872

5.  Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity.

Authors:  David R Gandara; Tianhong Li; Primo N Lara; Philip C Mack; Karen Kelly; Suzanne Miyamoto; Neal Goodwin; Laurel Beckett; Mary W Redman
Journal:  Clin Lung Cancer       Date:  2012-06-06       Impact factor: 4.785

6.  Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.

Authors:  Yasir H Ibrahim; Sara A Byron; Xiaojiang Cui; Adrian V Lee; Douglas Yee
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

7.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

Review 8.  Next generation oncology drug development: opportunities and challenges.

Authors:  Martin E Gutierrez; Shivaani Kummar; Giuseppe Giaccone
Journal:  Nat Rev Clin Oncol       Date:  2009-05       Impact factor: 66.675

Review 9.  Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer.

Authors:  Quanri Jin; Francisco J Esteva
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-25       Impact factor: 2.673

10.  Adeno-associated virus type 2 infection of nude mouse human breast cancer xenograft induces necrotic death and inhibits tumor growth.

Authors:  Samina Alam; Brian S Bowser; Mohd Israr; Michael J Conway; Craig Meyers
Journal:  Cancer Biol Ther       Date:  2014-05-16       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.